Drug
PF614 clinical trials
Also written PF614 and PRF06104.
- studies test it
- 7
- open now
- 2
- in phase 3
- 1
- first study started
- 2016
Keep track of what changes. Save the PF614 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 1
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 0
Ensysce Biosciences (7)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses PF614 is read from its arms, and is right about nine times in ten.
Testing it · 7
- Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)RecruitingPhase 1Ensysce BiosciencesNCT06500793Written as PF614 capsule
- PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)RecruitingPhase 3Ensysce BiosciencesNCT06602271Written as PF614 capsule
- Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)CompletedPhase 2Ensysce BiosciencesNCT06629402Written as PF614
- Study of PF614 Compared to OxyContin® in Healthy Volunteers (PF614-101)CompletedPhase 1Ensysce BiosciencesNCT02454712Written as PF614
- Pharmacokinetics of Oxycodone and PF614 Co-Administered with Nafamostat (PF614-MPAR-101)CompletedPhase 1Ensysce BiosciencesNCT05090280Written as PF614 solution
- A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-103)CompletedPhase 1Ensysce BiosciencesNCT05567354Written as PF614
- A Study to Evaluate the Oral Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-104)CompletedPhase 1Ensysce BiosciencesNCT05571345Written as PF614